[Gnumed-devel] Re: Drug interactions software -- significance and design considerations

[Jim Busser]

An interesting perspective on costs, suggesting users of an EMR may be well 
advised to use an EMR which licenses a 3rd party database instead of developing 
its own.

        http://www.medsp.com/ehro/ehr_rollout/ehro_post_support.php

I agree with the point about the duplication of work (cost) for everybody to be 
building their own.

They do also say

> Larger vendors will often point to the yearly fees they have to pay to their 
> middleware vendors as the justification for the higher maintenance fees and 
> to some degree this is true.

This, with FreeDiams, is not the case, however I can understand how companies 
which bring in revenues might spend extra time to improve their data sources.

What should be the thinking about allowing users to contribute interactions to 
FreeDiams, and of providing the references?